Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.
Saved in:
| Title: | Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets. |
|---|---|
| Authors: | Zhou H; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China., Xiang W; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China., Zhou G; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China., Rodrigues-Lima F; Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle Et Adaptative, 75013, Paris, France., Guidez F; Université Paris Cité, Institut de Recherche Saint Louis INSERM UMR_S1131, 75010, Paris, France., Wang L; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China. liwang@hospital.cqmu.edu.cn. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2024 Dec 07; Vol. 42 (1), pp. 23. Date of Electronic Publication: 2024 Dec 07. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
